ABBOTT PARK, Ill., Sept. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London on Thursday, Sept. 21. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at 3 a.m. U.S. Central time (9 a.m. London time).

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com . An archived edition of the presentation will be available later that day.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com .

SOURCE  Abbott
    -0-                             09/13/2006
    /CONTACT:  Media, Jonathon Hamilton, +1-847-935-8646, or Financial
Community, Larry Peepo, +1-847-935-6722, both of Abbott/
    /Company News On-Call:  http://www.prnewswire.com/comp/110328.html /
    /Web site:  http://www.abbott.com
                http://www.abbottinvestor.com /
    (ABT)

CO:  Abbott; Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
ST:  Illinois, England
IN:  HEA MTC BIO
SU:  TDS CCA

AB-SH
-- CGW066 --
1926 09/13/2006 14:56 EDT http://www.prnewswire.com